SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH
SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH
SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH 性质
| 储存条件 | -15°C |
|---|---|
| 形态 | 固体 |
| 颜色 | 白色至类白色 |
| 序列 | H-Ser-Gly-Ser-Ala-Lys-Val-Ala-Phe-Ser-Ala-Ile-Arg-Ser-Thr-Asn-His-OH |
SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH 用途与合成方法
Cerebellin concentration-dependently (from 1 to 100 nM) increases norepinephrine (but not epinephrine) and cyclic-AMP production by adrenomedullary tissue in vitro .
Cerebellin potently stimulates norepinephrine release by rat adrenal medulla, acting through adenylate-cyclase/PKA-coupled receptors, and enhances adrenocortical steroid secretion in vivo (i.e. when the integrity of adrenal gland is preserved) through an indirect paracrine mechanism involving the release of medullary catecholamines. Cerebellin reduces plasma insulin levels in rats after 1 and 2 h. Cerebellin decreases insulin secretion from isolated rat pancreatic islets at high (11 mM), but not at low (3.33 mM) glucose concentration. Cerebellin inhibits stimulated insulin secretion from clonal rat insulinoma (INS-1) cells, reduces forskolin-induced production of cAMP and intracellular calcium concentration.
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2023-03-20 | HY-P1544 | SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH | 94071-26-8 | 1mg | 2200 |
| 2023-03-20 | HY-P1544 | SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH | 94071-26-8 | 5mg | 6600 |
